| 1. Tenthorey PA, Adams HJ, Kronberg GH, Takman BH.. (1981) New antiarrhythmic agents. 7. 2,3-Diaminopropionanilides., 24 (9): [PMID:7288820] [10.1021/jm00141a008] |
| 2. Hankovszky OH, Hideg K, Bódi I, Frank L.. (1986) New antiarrhythmic agents. 2,2,5,5-Tetramethyl-3-pyrroline-3-carboxamides and 2,2,5,5-tetramethylpyrrolidine-3-carboxamindes., 29 (7): [PMID:3806567] [10.1021/jm00157a005] |
| 3. Jorgensen WL, Duffy EM.. (2000) Prediction of drug solubility from Monte Carlo simulations., 10 (11): [PMID:10866370] [10.1016/s0960-894x(00)00172-4] |
| 4. Lombardo F, Obach RS, Shalaeva MY, Gao F.. (2004) Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics., 47 (5): [PMID:14971904] [10.1021/jm030408h] |
| 5. Anger T, Madge DJ, Mulla M, Riddall D.. (2001) Medicinal chemistry of neuronal voltage-gated sodium channel blockers., 44 (2): [PMID:11170622] [10.1021/jm000155h] |
| 6. Suomalainen P, Johans C, Söderlund T, Kinnunen PK.. (2004) Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability., 47 (7): [PMID:15027870] [10.1021/jm0309001] |
| 7. Nelson PH, Strosberg AM, Untch KG.. (1980) Mono- and diaryl-2-quinuclidinylcarbinols with local anesthetic and antiarrhythmic activity., 23 (2): [PMID:7359531] [10.1021/jm00176a014] |
| 8. Stout DM, Black LA, Barcelon-Yang C, Matier WL, Brown BS, Quon CY, Stampfli HF.. (1989) Ester derivatives of 2,6-bis(1-pyrrolidinylmethyl)-4-benzamidophenol as short-acting antiarrhythmic agents. 1., 32 (8): [PMID:2754714] [10.1021/jm00128a037] |
| 9. Selassie CD, Hansch C, Khwaja TA.. (1990) Structure-activity relationships of antineoplastic agents in multidrug resistance., 33 (7): [PMID:2362268] [10.1021/jm00169a014] |
| 10. Sanfilippo PJ, Urbanski M, Press JB, Dubinsky B, Moore JB.. (1988) Synthesis of (aryloxy)alkylamines. 2. Novel imidazo-fused heterocycles with calcium channel blocking and local anesthetic activity., 31 (11): [PMID:3184128] [10.1021/jm00119a026] |
| 11. Morgan TK, Lis R, Marisca AJ, Argentieri TM, Sullivan ME, Wong SS.. (1987) Synthesis and cardiac electrophysiological activity of 2- and 3-[(substituted phenyl)alkyl]quinuclidines. Structure-activity relationships., 30 (12): [PMID:3681896] [10.1021/jm00395a014] |
| 12. Lombardo F, Shalaeva MY, Tupper KA, Gao F.. (2001) ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds., 44 (15): [PMID:11448232] [10.1021/jm0100990] |
| 13. Chorvat RJ, Black LA, Ranade VV, Barcelon-Yang C, Stout DM, Brown BS, Stampfli HF, Quon CY.. (1993) Mono- and bis(aminomethyl)phenylacetic acid esters as short-acting antiarrhythmic agents. 2., 36 (17): [PMID:8355250] [10.1021/jm00069a007] |
| 14. Garrison GL, Berlin KD, Scherlag BJ, Lazzara R, Patterson E, Fazekas T, Sangiah S, Chen CL, Schubot FD, van der Helm D.. (1996) Novel 3,7-diheterabicyclo[3.3.1]nonanes that possess predominant class III antiarrhythmic activity in 1-4 day post infarction dog models: X-ray diffraction analysis of 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3,7-diazabicyclo[3.3.1]nona ne dihydroperchlorate., 39 (13): [PMID:8691454] [10.1021/jm950772j] |
| 15. Yoshida F, Topliss JG.. (2000) QSAR model for drug human oral bioavailability., 43 (13): [PMID:10891117] [10.1021/jm0000564] |
| 16. Unger SH, Chiang GH.. (1981) Octanol-physiological buffer distribution coefficients of lipophilic amines by reversed-phase high-performance liquid chromatography and their correlation with biological activity., 24 (3): [PMID:6167716] [10.1021/jm00135a006] |
| 17. Lombardo F, Obach RS, Shalaeva MY, Gao F.. (2002) Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data., 45 (13): [PMID:12061889] [10.1021/jm0200409] |
| 18. Johnson RE, Baizman ER, Becker C, Bohnet EA, Bell RH, Birsner NC, Busacca CA, Carabateas PM, Chadwick CC, Gruett MD.. (1993) 4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents., 36 (22): [PMID:8230126] [10.1021/jm00074a017] |
| 19. Liberatore AM, Schulz J, Pommier J, Barthelemy MA, Huchet M, Chabrier PE, Bigg D.. (2004) 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators., 14 (13): [PMID:15177465] [10.1016/j.bmcl.2004.04.059] |
| 20. McNeal ET, Lewandowski GA, Daly JW, Creveling CR.. (1985) [3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs., 28 (3): [PMID:2579237] [10.1021/jm00381a019] |
| 21. Chrzanowski FA, McGrogan BA, Maryanoff BE.. (1985) The pKa of butaclamol and the mode of butaclamol binding to central dopamine receptors., 28 (3): [PMID:2579238] [10.1021/jm00381a022] |
| 22. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
| 23. Seidler J, McGovern SL, Doman TN, Shoichet BK.. (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs., 46 (21): [PMID:14521410] [10.1021/jm030191r] |
| 24. Tenthorey PA, Ronfeld RA, Feldman HS, Sandberg RV, McMaster PD, Smith ER.. (1981) New antiarrhythmic agents. 4. 1'-(Aminoalkyl)-1,2,3,4-tetrahydronaphthalene-1-spiro-3'-pyrrolidine-2',5'-dione derivatives., 24 (1): [PMID:7205874] [10.1021/jm00133a011] |
| 25. McMaster PD, Byrnes EW, Block AJ, Tenthorey PA.. (1981) New antiarrhythmic agents. 5. alpha-Aminoaceto-2,6-xylidides with functionalized amide alkyl substituents., 24 (1): [PMID:7205876] [10.1021/jm00133a012] |
| 26. Phillips GB, Morgan TK, Nickisch K, Lind JM, Gomez RP, Wohl RA, Argentieri TM, Sullivan ME.. (1990) Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents., 33 (2): [PMID:2299628] [10.1021/jm00164a025] |
| 27. Miyano S, Sumoto K, Satoh F, Shima K, Hayashimatsu M, Morita M, Aisaka K, Noguchi T.. (1985) New antiarrhythmic agents. N-aryl-8-pyrrolizidinealkanamides., 28 (6): [PMID:4009592] [10.1021/jm00383a005] |
| 28. Bailey BR, Berlin KD, Holt EM, Scherlag BJ, Lazzara R, Brachmann J, van der Helm D, Powell DR, Pantaleo NS, Ruenitz PC.. (1984) Synthesis, conformational analysis, and antiarrhythmic properties of 7-benzyl-3-thia-7-azabicyclo[3.3.1]nonan-9-one, 7-benzyl-3-thia-7-azabicyclo[3.3.1]nonane hydroperchlorate, and 7-benzyl-9-phenyl-3-thia-7-azabicyclo[3.3.1]nonan-9-ol hydroperchlorate and derivatives: single-crystal X-ray diffraction analysis and evidence for chair-chair and chair-boat conformers in the solid state., 27 (6): [PMID:6737418] [10.1021/jm00372a010] |
| 29. Thompson MD, Smith GS, Berlin KD, Holt EM, Scherlag BJ, van der Helm D, Muchmore SW, Fidelis KA.. (1987) Synthesis and antiarrhythmic properties of novel 3-selena-7-azabicyclo[3.3.1]nonanes and derivatives. Single-crystal X-ray diffraction analysis of 7-benzyl-3-selena-7-azabicyclo[3.3.1]nonan-9-one and 7-benzyl-3-selena-7-azabicyclo[3.3.1]nonane hydroperchlorate., 30 (5): [PMID:3572967] [10.1021/jm00388a006] |
| 30. Tenthorey PA, Block AJ, Ronfeld RA, McMaster PD, Byrnes EW.. (1981) New antiarrhythmic agents. 6. Quantitative structure-activity relationships of aminoxylidides., 24 (7): [PMID:7277383] [10.1021/jm00139a007] |
| 31. Caron G, Ermondi G.. (2005) Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk)., 48 (9): [PMID:15857133] [10.1021/jm048980b] |
| 32. Ottaviani G, Martel S, Carrupt PA.. (2006) Parallel artificial membrane permeability assay: a new membrane for the fast prediction of passive human skin permeability., 49 (13): [PMID:16789751] [10.1021/jm060230+] |
| 33. Vazzana I, Budriesi R, Terranova E, Ioan P, Ugenti MP, Tasso B, Chiarini A, Sparatore F.. (2007) Novel quinolizidinyl derivatives as antiarrhythmic agents., 50 (2): [PMID:17228875] [10.1021/jm060878m] |
| 34. Plouvier B, Beatch GN, Jung GL, Zolotoy A, Sheng T, Clohs L, Barrett TD, Fedida D, Wang WQ, Zhu JJ, Liu Y, Abraham S, Lynn L, Dong Y, Wall RA, Walker MJ.. (2007) Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation., 50 (12): [PMID:17506538] [10.1021/jm0604528] |
| 35. Ottaviani G, Martel S, Carrupt PA.. (2007) In silico and in vitro filters for the fast estimation of skin permeation and distribution of new chemical entities., 50 (4): [PMID:17300161] [10.1021/jm0611105] |
| 36. Baert B, Deconinck E, Van Gele M, Slodicka M, Stoppie P, Bodé S, Slegers G, Vander Heyden Y, Lambert J, Beetens J, De Spiegeleer B.. (2007) Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds., 15 (22): [PMID:17827020] [10.1016/j.bmc.2007.07.050] |
| 37. Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, Gulbins E.. (2008) Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model., 51 (2): [PMID:18027916] [10.1021/jm070524a] |
| 38. Henchoz Y, Guillarme D, Rudaz S, Veuthey JL, Carrupt PA.. (2008) High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists., 51 (3): [PMID:18189348] [10.1021/jm7014809] |
| 39. Costa JC, Neves JS, de Souza MV, Siqueira RA, Romeiro NC, Boechat N, e Silva PM, Martins MA.. (2008) Synthesis and antispasmodic activity of lidocaine derivatives endowed with reduced local anesthetic action., 18 (3): [PMID:18083513] [10.1016/j.bmcl.2007.11.122] |
| 40. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.. (2008) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors., 51 (21): [PMID:18834112] [10.1021/jm800656v] |
| 41. Santana L, González-Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, Orallo F.. (2008) Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors., 51 (21): [PMID:18834112] [10.1021/jm800656v] |
| 42. Wan H, Ahman M, Holmén AG.. (2009) Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs., 52 (6): [PMID:19256501] [10.1021/jm801441s] |
| 43. Bard B, Carrupt PA, Martel S.. (2009) Lipophilicity of basic drugs measured by hydrophilic interaction chromatography., 52 (10): [PMID:19397318] [10.1021/jm9003945] |
| 44. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P.. (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1., 51 (19): [PMID:18788725] [10.1021/jm8003152] |
| 45. Koini EN, Papazafiri P, Vassilopoulos A, Koufaki M, Horváth Z, Koncz I, Virág L, Papp GJ, Varró A, Calogeropoulou T.. (2009) 5,7,8-Trimethyl-benzopyran and 5,7,8-trimethyl-1,4-benzoxazine aminoamide derivatives as novel antiarrhythmics against ischemia-reperfusion injury., 52 (8): [PMID:19309156] [10.1021/jm801228h] |
| 46. Wassvik CM, Holmén AG, Draheim R, Artursson P, Bergström CA.. (2008) Molecular characteristics for solid-state limited solubility., 51 (10): [PMID:18396854] [10.1021/jm701587d] |
| 47. Coi A, Massarelli I, Testai L, Calderone V, Bianucci AM.. (2008) Identification of "toxicophoric" features for predicting drug-induced QT interval prolongation., 43 (11): [PMID:18262683] [10.1016/j.ejmech.2007.12.025] |
| 48. Geronikaki A, Vicini P, Dabarakis N, Lagunin A, Poroikov V, Dearden J, Modarresi H, Hewitt M, Theophilidis G.. (2009) Evaluation of the local anaesthetic activity of 3-aminobenzo[d]isothiazole derivatives using the rat sciatic nerve model., 44 (2): [PMID:18534720] [10.1016/j.ejmech.2008.04.006] |
| 49. Li H, Sun J, Sui X, Liu J, Yan Z, Liu X, Sun Y, He Z.. (2009) First-principle, structure-based prediction of hepatic metabolic clearance values in human., 44 (4): [PMID:18768239] [10.1016/j.ejmech.2008.07.027] |
| 50. Varma MV, Feng B, Obach RS, Troutman MD, Chupka J, Miller HR, El-Kattan A.. (2009) Physicochemical determinants of human renal clearance., 52 (15): [PMID:19445515] [10.1021/jm900403j] |
| 51. Lee PH, Conradi R, Shanmugasundaram V.. (2010) Development of an in silico model for human skin permeation based on a Franz cell skin permeability assay., 20 (1): [PMID:19963379] [10.1016/j.bmcl.2009.11.039] |
| 52. Du-Cuny L, Song Z, Moses S, Powis G, Mash EA, Meuillet EJ, Zhang S.. (2009) Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain., 17 (19): [PMID:19734051] [10.1016/j.bmc.2009.08.022] |
| 53. Wang Y, Jones PJ, Batts TW, Landry V, Patel MK, Brown ML.. (2009) Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore., 17 (19): [PMID:19346132] [10.1016/j.bmc.2008.10.031] |
| 54. Sui X, Sun J, Li H, Wang Y, Liu J, Liu X, Zhang W, Chen L, He Z.. (2009) Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data., 44 (11): [PMID:19586686] [10.1016/j.ejmech.2009.06.004] |
| 55. Tasso B, Budriesi R, Vazzana I, Ioan P, Micucci M, Novelli F, Tonelli M, Sparatore A, Chiarini A, Sparatore F.. (2010) Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation., 53 (12): [PMID:20509610] [10.1021/jm100298d] |
| 56. Feng BY, Toyama BH, Wille H, Colby DW, Collins SR, May BC, Prusiner SB, Weissman J, Shoichet BK.. (2008) Small-molecule aggregates inhibit amyloid polymerization., 4 (3): [PMID:18223646] [10.1038/nchembio.65] |
| 57. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
| 58. Gozalbes R, Pineda-Lucena A.. (2010) QSAR-based solubility model for drug-like compounds., 18 (19): [PMID:20810286] [10.1016/j.bmc.2010.08.003] |
| 59. Mo H, Balko KM, Colby DA.. (2010) A practical deuterium-free NMR method for the rapid determination of 1-octanol/water partition coefficients of pharmaceutical agents., 20 (22): [PMID:20864340] [10.1016/j.bmcl.2010.08.145] |
| 60. Alelyunas YW, Empfield JR, McCarthy D, Spreen RC, Bui K, Pelosi-Kilby L, Shen C.. (2010) Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate., 20 (24): [PMID:21055935] [10.1016/j.bmcl.2010.10.068] |
| 61. PubChem BioAssay data set, |
| 62. PubChem BioAssay data set, |
| 63. PubChem BioAssay data set, |
| 64. PubChem BioAssay data set, |
| 65. Ward KW, Nagilla R, Jolivette LJ.. (2005) Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human., 35 (2): [PMID:16019946] [10.1080/00498250400028197] |
| 66. Jolivette LJ, Ward KW.. (2005) Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure., 94 (7): [PMID:15920768] [10.1002/jps.20373] |
| 67. Obach RS, Lombardo F, Waters NJ.. (2008) Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds., 36 (7): [PMID:18426954] [10.1124/dmd.108.020479] |
| 68. Amr Ael-G, Sherif MH, Assy MG, Al-Omar MA, Ragab I.. (2010) Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4,5,6,7-tetrahydro-N-phenylbenzo[b]thiophene-3-carboxamide., 45 (12): [PMID:20950897] [10.1016/j.ejmech.2010.09.059] |
| 69. Sinha N, Sen S.. (2011) Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model., 46 (2): [PMID:21185626] [10.1016/j.ejmech.2010.11.042] |
| 70. Lowe R, Glen RC, Mitchell JB.. (2010) Predicting phospholipidosis using machine learning., 7 (5): [PMID:20799726] [10.1021/mp100103e] |
| 71. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
| 72. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
| 73. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
| 74. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF.. (2008) Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models., 18 (2): [PMID:20020916] [10.1080/15376510701857262] |
| 75. Unpublished dataset, |
| 76. PubChem BioAssay data set, |
| 77. PubChem BioAssay data set, |
| 78. Gozalbes R, Jacewicz M, Annand R, Tsaioun K, Pineda-Lucena A.. (2011) QSAR-based permeability model for drug-like compounds., 19 (8): [PMID:21458999] [10.1016/j.bmc.2011.03.011] |
| 79. Abraham MH, Ibrahim A, Acree WE.. (2008) Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs., 43 (3): [PMID:17544548] [10.1016/j.ejmech.2007.04.002] |
| 80. PubChem BioAssay data set, |
| 81. PubChem BioAssay data set, |
| 82. Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, Serabjit-Singh CS.. (2001) Rational use of in vitro P-glycoprotein assays in drug discovery., 299 (2): [PMID:11602674] |
| 83. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
| 84. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
| 85. Catalano A, Desaphy JF, Lentini G, Carocci A, Di Mola A, Bruno C, Carbonara R, De Palma A, Budriesi R, Ghelardini C, Perrone MG, Colabufo NA, Conte Camerino D, Franchini C.. (2012) Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels., 55 (3): [PMID:22191686] [10.1021/jm201197z] |
| 86. Ohashi R, Tamai I, Nezu Ji J, Nikaido H, Hashimoto N, Oku A, Sai Y, Shimane M, Tsuji A.. (2001) Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2., 59 (1): [PMID:11160873] [10.1124/mol.59.2.358] |
| 87. Nagy H, Goda K, Fenyvesi F, Bacsó Z, Szilasi M, Kappelmayer J, Lustyik G, Cianfriglia M, Szabó G.. (2004) Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies., 315 (1): [PMID:14985103] [10.1016/j.bbrc.2004.01.156] |
| 88. Wang E, Lew K, Barecki M, Casciano CN, Clement RP, Johnson WW.. (2001) Quantitative distinctions of active site molecular recognition by P-glycoprotein and cytochrome P450 3A4., 14 (1): [PMID:11743742] [10.1021/tx010125x] |
| 89. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
| 90. Joca HC, Cruz-Mendes Y, Oliveira-Abreu K, Maia-Joca RP, Barbosa R, Lemos TL, Lacerda Beirão PS, Leal-Cardoso JH.. (2012) Carvacrol decreases neuronal excitability by inhibition of voltage-gated sodium channels., 75 (9): [PMID:22967040] [10.1021/np300050g] |
| 91. Więckowski K, Sałat K, Bytnar J, Bajda M, Filipek B, Stables JP, Malawska B.. (2012) Search for anticonvulsant and analgesic active derivatives of dihydrofuran-2(3H)-one., 20 (21): [PMID:23010454] [10.1016/j.bmc.2012.08.037] |
| 92. Wittwer MB, Zur AA, Khuri N, Kido Y, Kosaka A, Zhang X, Morrissey KM, Sali A, Huang Y, Giacomini KM.. (2013) Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling., 56 (3): [PMID:23241029] [10.1021/jm301302s] |
| 93. Bagal SK, Brown AD, Cox PJ, Omoto K, Owen RM, Pryde DC, Sidders B, Skerratt SE, Stevens EB, Storer RI, Swain NA.. (2013) Ion channels as therapeutic targets: a drug discovery perspective., 56 (3): [PMID:23121096] [10.1021/jm3011433] |
| 94. Kalinin DV, Pantsurkin VI, Syropyatov BY, Kalinina SA, Rudakova IP, Vakhrin MI, Dolzhenko AV.. (2013) Synthesis, local anaesthetic and antiarrhythmic activities of N-alkyl derivatives of proline anilides., 63 [PMID:23474900] [10.1016/j.ejmech.2013.02.003] |
| 95. Nakamura Y, Fujimoto T, Ogawa Y, Namiki H, Suzuki S, Asano M, Sugita C, Mochizuki A, Miyazaki S, Tamaki K, Nagai Y, Inoue S, Nagayama T, Kato M, Chiba K, Takasuna K, Nishi T.. (2013) Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: discovery of DS-8108b, an orally active renin inhibitor., 21 (11): [PMID:23598247] [10.1016/j.bmc.2013.03.022] |
| 96. Settimo L, Bellman K, Knegtel RM.. (2013) Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds., [PMID:24249037] [10.1007/s11095-013-1232-z] |
| 97. Settimo L, Bellman K, Knegtel RM.. (2013) Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds., [PMID:24249037] [10.1007/s11095-013-1232-z] |
| 98. Settimo L, Bellman K, Knegtel RM.. (2013) Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds., [PMID:24249037] [10.1007/s11095-013-1232-z] |
| 99. Zha C, Brown GB, Brouillette WJ.. (2014) A highly predictive 3D-QSAR model for binding to the voltage-gated sodium channel: design of potent new ligands., 22 (1): [PMID:24332655] [10.1016/j.bmc.2013.11.049] |
| 100. Zidar N, Jakopin Ž, Madge DJ, Chan F, Tytgat J, Peigneur S, Dolenc MS, Tomašić T, Ilaš J, Mašič LP, Kikelj D.. (2014) Substituted 4-phenyl-2-aminoimidazoles and 4-phenyl-4,5-dihydro-2-aminoimidazoles as voltage-gated sodium channel modulators., 74 [PMID:24440379] [10.1016/j.ejmech.2013.12.034] |
| 101. PubChem BioAssay data set, |
| 102. PubChem BioAssay data set, |
| 103. Mateus A, Matsson P, Artursson P.. (2014) A high-throughput cell-based method to predict the unbound drug fraction in the brain., 57 (7): [PMID:24601604] [10.1021/jm401963n] |
| 104. Neumeyer JL, Perianayagam C, Ruchirawat S.. (1977) Isoquinolines. 5. Synthesis and antiarrhythmic activity of benzylisoquinoline derivatives., 20 (7): [PMID:874964] [10.1021/jm00217a005] |
| 105. McMaster PD, Byrnes EW, Feldman HS, Takman BH, Tenthorey PA.. (1979) New antiarrhythmic agents. 2. Amide alkyl alpha-amino xylidides., 22 (10): [PMID:513065] [10.1021/jm00196a006] |
| 106. Tenthorey PA, DiRubio RL, Feldman HS, Takman BH, Byrnes EW, McMaster PD.. (1979) New antiarrhythmic agents. 3. Primary beta-amino anilides., 22 (10): [PMID:513066] [10.1021/jm00196a007] |
| 107. Christy ME, Colton CD, Mackay M, Staas WH, Wong JB, Engelhardt EL, Torchiana M, Stone CA.. (1977) 2-, 3-, and 4-(alpha, alpha, beta, beta-tetrafluorophenethyl)benzylamines. A new class of antiarrhythmic agents., 20 (3): [PMID:845875] [10.1021/jm00213a021] |
| 108. Kornet MJ, Thio AP.. (1976) Oxindole-3-spiropyrrolidines and -piperidines. Synthesis and local anesthetic activity., 19 (7): [PMID:940109] [10.1021/jm00229a007] |
| 109. Banitt EH, Bronn WR, Coyne WE, Schmid JR.. (1977) Antiarrhythmics. 2. Synthesis and antiarrhythmic activity of N-(piperidylalkyl)trifluoroethoxybenzamides., 20 (6): [PMID:874956] [10.1021/jm00216a016] |
| 110. Waraszkiewicz SM, Foye WO, Adams HJ, Takman BH.. (1976) Local anesthetics. 2-Diethylamino-2',6'-acylxylidides., 19 (4): [PMID:1263207] [10.1021/jm00226a019] |
| 111. Nelson SD, Nelson WL, Trager WF.. (1978) N-Hydroxyamide metabolites of lidocaine. Synthesis, characterization, quantitation, and mutagenic potential., 21 (8): [PMID:690997] [10.1021/jm00206a001] |
| 112. Więckowska A, Więckowski K, Bajda M, Brus B, Sałat K, Czerwińska P, Gobec S, Filipek B, Malawska B.. (2015) Synthesis of new N-benzylpiperidine derivatives as cholinesterase inhibitors with β-amyloid anti-aggregation properties and beneficial effects on memory in vivo., 23 (10): [PMID:25868744] [10.1016/j.bmc.2015.03.051] |
| 113. Guzior N, Bajda M, Rakoczy J, Brus B, Gobec S, Malawska B.. (2015) Isoindoline-1,3-dione derivatives targeting cholinesterases: design, synthesis and biological evaluation of potential anti-Alzheimer's agents., 23 (7): [PMID:25707322] [10.1016/j.bmc.2015.01.045] |
| 114. Di L, Umland JP, Chang G, Huang Y, Lin Z, Scott DO, Troutman MD, Liston TE.. (2011) Species independence in brain tissue binding using brain homogenates., 39 (7): [PMID:21474681] [10.1124/dmd.111.038778] |
| 115. Farrell TL, Poquet L, Dew TP, Barber S, Williamson G.. (2012) Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study., 40 (2): [PMID:22096083] [10.1124/dmd.111.041665] |
| 116. Zanelli U, Caradonna NP, Hallifax D, Turlizzi E, Houston JB.. (2012) Comparison of cryopreserved HepaRG cells with cryopreserved human hepatocytes for prediction of clearance for 26 drugs., 40 (1): [PMID:21998403] [10.1124/dmd.111.042309] |
| 117. Vivier D, Bennis K, Lesage F, Ducki S.. (2016) Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?, 59 (11): [PMID:26588045] [10.1021/acs.jmedchem.5b00671] |
| 118. WHO Anatomical Therapeutic Chemical Classification, |
| 119. British National Formulary (72nd edition), |
| 120. Monteillier A, Loucif A, Omoto K, Stevens EB, Lainez S, Saintot PP, Cao L, Pryde DC.. (2016) Investigation of the structure activity relationship of flufenamic acid derivatives at the human TRESK channel K2P18.1., 26 (20): [PMID:27641472] [10.1016/j.bmcl.2016.09.020] |
| 121. Košak U, Knez D, Coquelle N, Brus B, Pišlar A, Nachon F, Brazzolotto X, Kos J, Colletier JP, Gobec S.. (2017) N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents., 25 (2): [PMID:27908752] [10.1016/j.bmc.2016.11.032] |
| 122. Więckowska A, Kołaczkowski M, Bucki A, Godyń J, Marcinkowska M, Więckowski K, Zaręba P, Siwek A, Kazek G, Głuch-Lutwin M, Mierzejewski P, Bienkowski P, Sienkiewicz-Jarosz H, Knez D, Wichur T, Gobec S, Malawska B.. (2016) Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation., 124 [PMID:27560283] [10.1016/j.ejmech.2016.08.016] |
| 123. DrugMatrix, [10.6019/CHEMBL3885881] |
| 124. DailyMed|setid=823c2d42-d00d-401d-4081-fc1d434455e0 | EMLA- lidocaine cream|APP Pharmaceuticals, LLC, |
| 125. DailyMed|setid=1b5826d4-5177-42b9-8ac2-d35071b4bccb | DENTIPATCH- lidocaine patch|Noven Parmaceuticals, Inc., |
| 126. Elkamhawy A, Park JE, Hassan AHE, Ra H, Pae AN, Lee J, Park BG, Moon B, Park HM, Roh EJ.. (2017) Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction., 128 [PMID:28152427] [10.1016/j.ejmech.2016.12.057] |
| 127. Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK.. (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development., 118 (2): [PMID:20829430] [10.1093/toxsci/kfq269] |
| 128. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101] [10.1093/toxsci/kft176] |
| 129. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
| 130. Unpublished dataset, |
| 131. Katie Heiser, Peter F. McLean, Chadwick T. Davis, Ben Fogelson, Hannah B. Gordon, Pamela Jacobson, Brett Hurst, Ben Miller, Ronald W. Alfa, Berton A. Earnshaw, Mason L. Victors, Yolanda T. Chong, Imran S. Haque, Adeline S. Low, Christopher C. Gibson. (2020) Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2, [10.1101/2020.04.21.054387] |
| 132. Bedoya M, Rinné S, Kiper AK, Decher N, González W, Ramírez D.. (2019) TASK Channels Pharmacology: New Challenges in Drug Design., 62 (22): [PMID:31260312] [10.1021/acs.jmedchem.9b00248] |
| 133. (2013) Method for treating skin with retinoids and retinoid boosters, |
| 134. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of NIH (USA) - Clinical Collection, [10.6019/CHEMBL4513141] |
| 135. Ellen Van Damme. (2021) Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity, [10.6019/CHEMBL4651402] |
| 136. Košak U,Strašek N,Knez D,Jukič M,Žakelj S,Zahirović A,Pišlar A,Brazzolotto X,Nachon F,Kos J,Gobec S. (2020) N-alkylpiperidine carbamates as potential anti-Alzheimer's agents., 197 [PMID:32380361] [10.1016/j.ejmech.2020.112282] |
| 137. Bernhard Ellinger, Justus Dick, Vanessa Lage-Rupprecht, Bruce Schultz, Andrea Zaliani, Marcin Namysl, Stephan Gebel, Ole Pless, Jeanette Reinshagen, Christian Ebeling, Alexander Esser, Marc Jacobs, Carsten Claussen, and Martin Hofmann-Apitius. (2021) HDAC6 screening dataset using tau-based substrate in an enzymatic assay yields selective inhibitors and activators, [10.6019/CHEMBL4808148] |
| 138. Dąbrowska M, Starek M, Chłoń-Rzepa G, Zagórska A, Komsta Ł, Jankowska A, Ślusarczyk M, Pawłowski M.. (2021) Estimation of the lipophilicity of purine-2,6-dione-based TRPA1 antagonists and PDE4/7 inhibitors with analgesic activity., 49 [PMID:34391892] [10.1016/j.bmcl.2021.128318] |
| 139. Zheng M, Li C, Zhou M, Jia R, Cai G, She F, Wei L, Wang S, Yu J, Wang D, Calcul L, Sun X, Luo X, Cheng F, Li Q, Wang Y, Cai J.. (2021) Discovery of Cyclic Peptidomimetic Ligands Targeting the Extracellular Domain of EGFR., 64 (15.0): [PMID:34297567] [10.1021/acs.jmedchem.1c00607] |
| 140. Kitano Y, Shinozuka T.. (2022) Inhibition of NaV1.7: the possibility of ideal analgesics., 13 (8.0): [PMID:36092147] [10.1039/d2md00081d] |
| 141. Vallaro M, Ermondi G, Saame J, Leito I, Caron G.. (2023) Ionization and lipophilicity in nonpolar media mimicking the cell membrane interior., 81 [PMID:36796127] [10.1016/j.bmc.2023.117203] |
| 142. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
